Sutro Biopharma (STRO) Return on Assets [ROA] (2018 - 2026)
Sutro Biopharma's Return on Assets [ROA] was -83.44% in Q2 2026, down 15.57 percentage points from -67.86% a year earlier.
Powered by 
Analysis
Sutro Biopharma (STRO) Return on Assets [ROA] (2018 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Sutro Biopharma came in at -68.12%, down 15.08 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of -56.44 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -53.03% in FY2024 (-28.70 pp), -24.34% in FY2023 (+7.52 pp), -31.86% in FY2022 (-3.16 pp) and -28.70% in FY2021 (-17.02 pp).
- Quarterly Return on Assets [ROA] has moved between -94.10% (Q4 2025) and -23.14% (Q3 2021) over five years.
- Compared with a year earlier, Return on Assets [ROA] was higher in 1 of the last seven quarters, with an average year-over-year change of -30.68 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q3 2024 (a gain of 12.12 percentage points); the worst was Q3 2025 (a drop of 61.00 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 2.14% |
| 10 | Sutro Biopharma | 264.72 Mn | -413.78 Mn | - | -83.44% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -83.44% |
| Dec 31, 2025 | -94.10% |
| Sep 30, 2025 | -87.35% |
| Jun 30, 2025 | -67.86% |
| Mar 31, 2025 | -66.21% |
| Dec 31, 2024 | -54.23% |
| Sep 30, 2024 | -26.35% |
| Jun 30, 2024 | -27.89% |
| Mar 31, 2024 | -26.30% |
| Dec 31, 2023 | -23.67% |
| Sep 30, 2023 | -38.47% |
| Jun 30, 2023 | -34.67% |
| Mar 31, 2023 | -34.03% |
| Dec 31, 2022 | -29.52% |
| Sep 30, 2022 | -31.22% |
| Jun 30, 2022 | -38.92% |
| Mar 31, 2022 | -35.43% |
| Dec 31, 2021 | -26.61% |
| Sep 30, 2021 | -23.14% |
| Jun 30, 2021 | -18.47% |
API Access
Sutro Biopharma Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=STRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "STRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=STRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();